Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN74843649
ISRCTN74843649
Completed
N/A

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

HS R&D Regional Programme Register - Department of Health (UK)0 sites2,002 target enrollmentJanuary 23, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCardiovascular diseases: Heart diseaseCirculatory SystemHeart disease

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular diseases: Heart disease
Sponsor
HS R&D Regional Programme Register - Department of Health (UK)
Enrollment
2002
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
HS R&D Regional Programme Register - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • •Patients with angiographically proven coronary atherosclerosis

Exclusion Criteria

  • •Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of supplementation in treatment of patients with diabetic nephropathyDiabetic nephropathy.Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2+)N08.3
IRCT201706055623N117Vice chancellor for research, Kashan University of Medical Sciences54
Completed
Phase 3
Effect of combined vitamin E and zinc supplementation in treatment of gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9
IRCT20170513033941N26ational Institute for Medical Research Development of Iran (NIMAD)60
Completed
N/A
Effect of vitamin E in the treatment of UTI in childrerinary Tract Infection.Urinary tract infection, site not specified
IRCT201305199766N2Arak University of Medical Sciences152
Not Yet Recruiting
Phase 2
Investigating the effectiveness of vitamin E drug in reducing the incidence of chronic neurotoxicity caused by oxaliplatin drugDrug-induced neurotoxicity.Drug-induced neurotoxicity62.0
IRCT20180313039085N3Iran University of Medical Sciences60
Completed
N/A
VITAL: VITamin E and Anaemia in dialysis patients in LeedsTopic: Renal and UrogenitalSubtopic: Renal and Urogenital (all Subtopics)Disease: RenalUrological and Genital DiseasesUnspecified renal failure
ISRCTN12650766eeds Teaching Hospitals NHS Trust (UK)348